GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
134 hedge funds and large institutions have $870M invested in Genomic Health, Inc. in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 53 increasing their positions, 42 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $220K
Holders
134
Holding in Top 10
2
Calls
$1K
Puts
$220K
Top Buyers
| 1 | +$13.6M | |
| 2 | +$8.42M | |
| 3 | +$7.09M | |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$3.3M |
| 5 |
Renaissance Technologies
New York
|
+$3.22M |
Top Sellers
| 1 | -$16.5M | |
| 2 | -$7.37M | |
| 3 | -$7M | |
| 4 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$6.74M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.41M |